Toggle navigation
English
Ελληνικά
Deutsch
français
italiano
español
italiano
English
Ελληνικά
Deutsch
français
italiano
español
Login
Toggle navigation
Mostra Item
DSpace Home
Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
Mostra Item
DSpace Home
Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
Mostra Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tutto DSpace
Archivi & Collezioni
Data di pubblicazione
Autori
Titoli
Soggetti
Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: Tumor mutation burden and PD-L1 ≥50%
Autore
Zarogoulidis P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y.-G., Bai C., Huang H.
Data
2018
Language
en
DOI
10.21037/tlcr.2018.01.04
Soggetto
nivolumab
pembrolizumab
programmed death 1 ligand 1
cancer chemotherapy
cancer immunotherapy
drug safety
Editorial
gene mutation
human
liver metastasis
non small cell lung cancer
overall survival
protein expression
tumor biopsy
AME Publishing Company
Mostra tutti i dati dell'item
Abstract
[No abstract available]
URI
http://hdl.handle.net/11615/80964
Collections
Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
[19705]
Cerca in DSpace
Questa Collezione
Ricerca
Tutto DSpace
Archivi & Collezioni
Data di pubblicazione
Autori
Titoli
Soggetti
Questa Collezione
Data di pubblicazione
Autori
Titoli
Soggetti
My Account
Login
Registrazione
Help Contact
Deposition
About
Help
Contattaci
Choose Language
Tutto DSpace
English
Ελληνικά